Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.39 |
| ▸ | FABP7 | O15540 | 2/20 | 0.39 |
| ▸ | MDM4 | O15151 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PARP1 | P09874 | 3/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25816888 | 1.00 | FABP5 (0.39) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL29727826 | 0.90 | PREP (0.40) | PARP1 | |
| SCHEMBL29397992 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL31437115 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL8131557 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL29398490 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL29984898 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL15673443 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL30537965 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 | |
| SCHEMBL118220 | 0.85 | FABP5 (0.41) | FABP5FABP7MDM4TP53AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230220001-A1 | METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220001-A1 | METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES | TST, PTMS, CTH | FABP5 1197/4885FABP7 496/4885MDM4 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.